SCHEMBL17876296

SCHEMBL17876296

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-c5cccc6c5oc5ccccc56)ccc3CN(c3ccccc3)C4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
PRKDC P78527 10/20 0.43
PIK3CD O00329 4/20 0.39
PIK3CB P42338 4/20 0.39
ATM Q13315 1/20 0.39
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GGPS1 O95749 1/20 0.37
PIK3CA P42336 3/20 0.36
PIK3CG P48736 3/20 0.36
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PDE2A O00408 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876275 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876231 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876294 0.91 ALOX5 (0.48) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876289 0.89 ALOX5 (0.53) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876308 0.89 ALDH1A1 (0.38) PRKDCKDM4EALDH1A1MAPTHPGD
SCHEMBL17876309 0.88 MAPT (0.40) PRKDCKDM4EALDH1A1MAPTHPGD
SCHEMBL17876302 0.88 MAPT (0.40) PRKDCATMKDM4EALDH1A1MAPT
SCHEMBL17876259 0.87 ALOX5 (0.45) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876230 0.87 ALOX5 (0.45) ALOX5PRKDCPIK3CDPIK3CBATM
SCHEMBL17876290 0.86 ALOX5 (0.48) ALOX5PRKDCPIK3CDPIK3CBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885PIK3CD 4652/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885PIK3CD 4652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.